Skip to main content
. 2022 Jul 8;2022:5228874. doi: 10.1155/2022/5228874

Figure 3.

Figure 3

MiR-193a-5p targets GPX4 in cervical cancer cells. (a) The predicted interaction site between miR-193a-5p and GPX4. (b)–(e) SiHa and HeLa cells treated with miR-193a-5p mimic. (b), (c) The luciferase activity of GPX4 determined by dual luciferase reporter assay. (d) The expression of GPX4 measured by qPCR. (e) SiHa and HeLa cells treated with circACAP2 siRNA or cotreated with the miR-193a-5p inhibitor. The expression of GPX4 was analyzed by qPCR. ∗∗P < 0.01.